Adventmed Biogenerics Private Limited - Company Profile

It is a professional services private limited company based in Mumbai, Maharashtra, India, established in 2012.
2012 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Adventmed Biogenerics Private Limited

Adventmed Biogenerics Private Limited, a struck off private limited company, was established on 13 March 2012 in Mumbai, Maharashtra, India. Engaging in technical within the professional services sector, it holds CIN: U74120MH2012PTC228021. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sudha Pradeep Nambiar (Director), Lata Ganga Mohan Menon (Additional Director). Past directors included Puthenkalam Narayanan Kutty Menon Ganga Mohan. Its latest AGM occurred on 30 September 2015, with the balance sheet filed on 31 March 2015. It is based at C-403, Silver Leaf, Akurli Road, Kandivali (East), Mumbai, Maharashtra, 400101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74120MH2012PTC228021

  • Registration Number

    228021

  • Incorporation Date

    13 March 2012

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 11 Months
  • Last Filing with ROC 31 Mar 2015
Company report

Adventmed Biogenerics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Adventmed Biogenerics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Adventmed Biogenerics Private Limited?
Current Directors
Name Designation Appointment Date Status
Sudha Pradeep Nambiar Director 13 Mar 2012 Current
Lata Ganga Mohan Menon Additional Director 04 Apr 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 14 Apr 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Adventmed Biogenerics.

Enhance accessibility to Adventmed Biogenerics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Adventmed Biogenerics revenue growth over time
Adventmed Biogenerics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Adventmed Biogenerics?

Unlock access to Adventmed Biogenerics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Adventmed Biogenerics?

Unlock and access historical data on people associated with Adventmed Biogenerics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Adventmed Biogenerics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adventmed Biogenerics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Adventmed Biogenerics
Recent Activity within the Organization
  • Director Appointment

    Progress on Lata Ganga Mohan Menon was appointed as a Additional Director was appointed as a Additional Director on 04 Apr 2016 & has been associated with this company since 9 years 10 months . was documented.

  • Annual General Meeting

    Progress on Adventmed Biogenerics Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records. was documented.

  • Balance Sheet

    Adventmed Biogenerics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Progress on Sudha Pradeep Nambiar was appointed as a Director was appointed as a Director on 13 Mar 2012 & has been associated with this company since 13 years 11 months . was documented.

  • Company Incorporation

    Progress on Adventmed Biogenerics Private Limited was registered on 13 Mar 2012 with Roc Mumbai & aged 13 years 11 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Adventmed Biogenerics Private Limited?

The CIN of Adventmed Biogenerics Private Limited is U74120MH2012PTC228021.

Where is Adventmed Biogenerics Private Limited headquartered?

Adventmed Biogenerics Private Limited is headquartered at C-403, Silver Leaf, Akurli Road, Kandivali (East), Mumbai, Maharashtra, 400101.

When was Adventmed Biogenerics Private Limited incorporated?

Adventmed Biogenerics Private Limited was incorporated on 13 March 2012.

Who are the current directors of Adventmed Biogenerics Private Limited?

The current directors of Adventmed Biogenerics Private Limited are

What is the primary industry of Adventmed Biogenerics Private Limited?

The primary industry of Adventmed Biogenerics Private Limited is Professional Services.

Is Adventmed Biogenerics Private Limited a listed company?

Adventmed Biogenerics Private Limited is unlisted.

What is the capital structure of Adventmed Biogenerics Private Limited?

The authorized capital of Adventmed Biogenerics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available